NEOCINE Trademark of NeoCine Therapeutics Inc. - Serial Number 98777335

NEOCINE Trademark

Trademark Overview

On Monday, September 30, 2024, a trademark application was filed for NEOCINE with the United States Patent and Trademark Office. The USPTO has given the NEOCINE trademark a serial number of 98777335. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Monday, September 30, 2024. This trademark is owned by NeoCine Therapeutics Inc.. The NEOCINE trademark is filed in the Pharmaceutical Products, Computer & Software Products & Electrical & Scientific Products, Computer & Software Services & Scientific Services, and Medical & Beauty Services & Agricultural Services categories with the following description:

Computer software for the identification and analysis of neoepitopes that control tumors in vivo; software platforms for processing cancer and normal protein sets, identifying high-quality patient-specific neoepitopes, and designing personalized cancer vaccines; bioinformatics software for predicting the immunogenicity of neoepitopes and aiding in the design of targeted cancer therapies

Pharmaceutical preparations for the treatment and prevention of cancer; biological preparations for medical use in the treatment of cancer; immunotherapeutic pharmaceutical products including personalized vaccines designed to treat cancer by targeting specific neoepitopes that control tumors in vivo; anti-cancer drugs; therapeutic vaccines; diagnostic preparations for medical purposes, including those used to identify neoepitopes associated with tumor control

Medical analysis services for the treatment of cancer, including the identification and analysis of neoepitopes that control tumors in vivo; medical services, namely, providing therapies for treating cancer; medical testing and diagnostic services for processing cancer and normal protein sets to identify high-quality patient-specific neoepitopes for personalized cancer vaccine development; preparation and dispensing of personalized immunotherapies, including neoepitope-based cancer vaccines tailored to individual patient profiles

Scientific research and development in the field of oncology, specifically focused on identifying and analyzing neoepitopes that control tumors in vivo for the development of personalized cancer vaccines; medical and scientific research related to the processing of cancer and normal protein sets, identification of high-quality patient-specific neoepitopes, and design of immunotherapeutic treatments; providing temporary use of non-downloadable software for the prediction of neoepitope immunogenicity and the design of targeted cancer vaccines

General Information

Serial Number	98777335
Word Mark	NEOCINE
Filing Date	Monday, September 30, 2024
Status	630 - NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER
Status Date	Monday, September 30, 2024
Registration Number	0000000
Registration Date	NOT AVAILABLE
Mark Drawing	4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition Date	NOT AVAILABLE

Trademark Statements

Goods and Services	Computer software for the identification and analysis of neoepitopes that control tumors in vivo; software platforms for processing cancer and normal protein sets, identifying high-quality patient-specific neoepitopes, and designing personalized cancer vaccines; bioinformatics software for predicting the immunogenicity of neoepitopes and aiding in the design of targeted cancer therapies
Goods and Services	Pharmaceutical preparations for the treatment and prevention of cancer; biological preparations for medical use in the treatment of cancer; immunotherapeutic pharmaceutical products including personalized vaccines designed to treat cancer by targeting specific neoepitopes that control tumors in vivo; anti-cancer drugs; therapeutic vaccines; diagnostic preparations for medical purposes, including those used to identify neoepitopes associated with tumor control
Goods and Services	Medical analysis services for the treatment of cancer, including the identification and analysis of neoepitopes that control tumors in vivo; medical services, namely, providing therapies for treating cancer; medical testing and diagnostic services for processing cancer and normal protein sets to identify high-quality patient-specific neoepitopes for personalized cancer vaccine development; preparation and dispensing of personalized immunotherapies, including neoepitope-based cancer vaccines tailored to individual patient profiles
Goods and Services	Scientific research and development in the field of oncology, specifically focused on identifying and analyzing neoepitopes that control tumors in vivo for the development of personalized cancer vaccines; medical and scientific research related to the processing of cancer and normal protein sets, identification of high-quality patient-specific neoepitopes, and design of immunotherapeutic treatments; providing temporary use of non-downloadable software for the prediction of neoepitope immunogenicity and the design of targeted cancer vaccines

Classification Information

International Class	005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes	005, 006, 018, 044, 046, 051, 052
Class Status Code	6 - Active
Class Status Date	Monday, September 30, 2024
Primary Code	005
First Use Anywhere Date	NOT AVAILABLE
First Use In Commerce Date	NOT AVAILABLE

International Class	009 - Scientific, nautical, surveying, photographic, cinematographic, optical, weighing, measuring, signalling, checking (supervision), life-saving and teaching apparatus and instruments; apparatus and instruments for conducting, switching, transforming, accumulating, regulating or controlling electricity; apparatus for recording, transmission or reproduction of sound or images; magnetic data carriers, recording discs; automatic vending machines and mechanisms for coin operated apparatus; cash registers, calculating machines, data processing equipment and computers; fire extinguishing apparatus.
US Class Codes	021, 023, 026, 036, 038
Class Status Code	6 - Active
Class Status Date	Monday, September 30, 2024
Primary Code	009
First Use Anywhere Date	NOT AVAILABLE
First Use In Commerce Date	NOT AVAILABLE

International Class	042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software.
US Class Codes	100, 101
Class Status Code	6 - Active
Class Status Date	Monday, September 30, 2024
Primary Code	042
First Use Anywhere Date	NOT AVAILABLE
First Use In Commerce Date	NOT AVAILABLE

International Class	044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes	100, 101
Class Status Code	6 - Active
Class Status Date	Monday, September 30, 2024
Primary Code	044
First Use Anywhere Date	NOT AVAILABLE
First Use In Commerce Date	NOT AVAILABLE

Trademark Owner History

Party Name	NeoCine Therapeutics Inc.
Party Type	10 - Original Applicant
Legal Entity Type	03 - Corporation
Address	Wilmington, DE 19803

Trademark Events

Event Date	Event Description
Monday, September 30, 2024	NEW APPLICATION ENTERED

Related Keywords

neocine cancer neoepitopes vaccines medical control personalized specific including vivo software